Dr. Ariel Soffer, MD, FACC
Founder & Clinical Architect, Soffer Longevity
Dr. Ariel Soffer is a board-certified cardiologist, physician-innovator, and nationally recognized educator whose career has been defined by one core principle: medicine must advance, but never outrun evidence or clinical judgment.
After graduating with Distinction from the University of Miami School of Medicine in 1990, Dr. Soffer was recruited to Cedars-Sinai Medical Center in Beverly Hills. He completed his training in Internal Medicine and Cardiovascular Disease through programs affiliated with UCLA and USC, before returning to Miami to build a practice centered on improving both lifespan and healthspan.
For more than three decades, Dr. Soffer has practiced at the intersection of traditional cardiovascular medicine and leading edge science. He has developed and patented multiple medical technologies, leading to several successful healthcare companies, and has authored numerous peer-reviewed publications and books. His ability to translate complex medicine into clear, actionable guidance reached a national audience through ABC News, which produced Dr. Soffer’s Second Opinion, a medical segment that aired for multiple years.
A lifelong teacher, Dr. Soffer has trained hundreds of physicians worldwide and continues as a Professor teaching medical students weekly at Nova Southeastern University’s College of Allopathic Medicine.. His educational mission also extends to the his acclaimed podcast, where he helps viewers better understand modern medicine and make informed health decisions.
Soffer Longevity Philosophy
Dr. Soffer founded Soffer Longevity to address a growing gap in modern healthcare: the absence of a rigorous, physician-led framework for evaluating longevity and healthspan interventions.
Unlike many longevity clinics driven by trends, Soffer Longevity is built on a graded evidence model (A–F) that systematically reviews emerging diagnostics, therapeutics, supplements, technologies, and lifestyle interventions. Each recommendation is assessed for:
- Scientific validity
- Clinical relevance
- Safety profile
- Strength of evidence
- Applicability to the individual patient
Only things that meet Soffer Longevity’s highest standards are actively recommended, while lower-grade or experimental options are clearly disclosed, contextualized, and personalized, never marketed indiscriminately.
